Cargando…
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
OBJECTIVE: To assess whether genetic subgroups in recent amyotrophic lateral sclerosis (ALS) trials responded to treatment with lithium carbonate, but that the treatment effect was lost in a large cohort of nonresponders. METHODS: Individual participant data were obtained from 3 randomized trials in...
Autores principales: | van Eijk, Ruben P.A., Jones, Ashley R., Sproviero, William, Shatunov, Aleksey, Shaw, Pamela J., Leigh, P. Nigel, Young, Carolyn A., Shaw, Christopher E., Mora, Gabriele, Mandrioli, Jessica, Borghero, Giuseppe, Volanti, Paolo, Diekstra, Frank P., van Rheenen, Wouter, Verstraete, Esther, Eijkemans, Marinus J.C., Veldink, Jan H., Chio, Adriano, Al-Chalabi, Ammar, van den Berg, Leonard H., van Es, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664299/ https://www.ncbi.nlm.nih.gov/pubmed/28978660 http://dx.doi.org/10.1212/WNL.0000000000004606 |
Ejemplares similares
-
Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019) -
Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2018) -
Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study
por: Janse van Mantgem, Mark R., et al.
Publicado: (2023) -
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study
por: van Rheenen, Wouter, et al.
Publicado: (2018) -
Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis
por: Gaastra, Benjamin, et al.
Publicado: (2016)